Modulation of genes involved in zinc homeostasis in old low-grade atherosclerotic patients under effects of HMG-CoA reductase inhibitors

Rejuvenation Research

Volumn 11, Issue 2, 2008, Pages 287-291

  Costarelli, Laura ^a,c   Muti, Elisa ^a   Malavolta, Marco ^a   Giacconi, Robertina ^a   Cipriano, Catia ^a   Sartini, Davide ^b   Emanuelli, Monica ^b   Silvestrini, Mauro ^b   Provinciali, Leandro ^b   Gobbi, Beatrice ^b   Mocchegiani, Eugenio ^a  

^a Section of Nutrition Immunity and Ageing   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; SIMVASTATIN; ZINC;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INFLAMMATION; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; AGING; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; ZINC;

EID: 42649116762     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0665     Document Type: Article

References (20)

1. Giacconi R, Muti E, Malavolta M, Cipriano C, Costarelli L, Bernardini G, Gasparini N, Mariani E, Saba V, Boccoli G, Mocchegiani E. +838 C/G MT2A polymorphism, metals and inflammatory/immune response in carotid artery stenosis in elderly people. Mol Med 2007;13:388-395.
2. Gomez NN, Biaggio VS, Rozzen EJ, Alvarez SM, Gimenez MS. Zn-limited diet modifies the expression of the rate-regulatory enzymes involved in phosphatidylcholine and cholesterol synthesis.Br J Nutr 2006;96:1038-1046.
3. Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med 2007;147:1-9.
4. Yilmaz MI, Baykal Y, Kilic M, Sonmez A, Bulucu F, Aydin A, Sayal A, Kocar IH. Effects of statins on oxidative stress. Biol Trace Elem Res 2004;98:119-127.
5. Leonhardt W, Kurktschiev T, Meissner D, Lattke P, Abletshauser C, Weidinger G, Jaross W, Hanefeld M. Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals. Eur J Clin Pharmacol 1997;53:65-69.
6. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol 2006;41:1094-1107.
7. Malavolta M, Costarelli L, Giacconi R, Muti E, Bernardini G, Tesei S, Cipriano C, Mocchegiani E. Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 2006;169:1043-1053.
8. Andree KB, Kim J, Kirschke CP, Gregg JP, Paik H, Joung H, Woodhouse L, King JC, Huang L. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J Nutr 2004;134:1716-1723.
9. Kindermann B, Doring F, Pfaffl M, Daniel H. Identification of genes responsive to intracellular zinc depletion in the human colon adenocarcinoma cell line HT-29. J Nutr 2004;134:57-62.
10. Haase H, Mazzatti DJ, White A, Ibs KH, Engelhardt G, Hebel S, Powell JR, Rink L. Differential gene expression after zinc supplementation and deprivation in human leukocyte subsets. Mol Med 2007;13:62-70.
11. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002;33:1782-1785.
12. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, Lakatta EG. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996;148:121-128.
13. Cooney MT, Dudina AL, O'callaghan P, Graham IM. Von Willebrand factor in CHD and stroke: relationships and therapeutic implications. Curr Treat Options Cardiovasc Med 2007;9:180-190.
14. Francis GA, Annicotte JS, Auwerx J. PPAR agonists in the treatment of atherosclerosis. Curr Opin Pharmacol 2003;3:186-191.
15. Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F, Sevestre H, Krimpenfort P, Corsini A, Rochette J, Glineur C, Fruchart JC, Torpier G, Staels B. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J Clin Invest 2005;115:3228-3238.
16. Mantuano E, Santi S, Filippi C, Manca-Rizza G, Paoletti S, Consani C, Giovannini L, Tramonti G, Carpi A, Panichi V. Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients. Biomed Pharmacother 2007;61:360-365.
17. Wibaut-Berlaimont V, Randi AM, Mandryko V, Lunnon MW, Haskard DO, Naoumova RP. Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J Thromb Haemost 2005;3:677-685.
18. Suzuki T, Ishihara K, Migaki H, Ishihara K, Nagao M, Yamaguchi-Iwai Y, Kambe T. Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells. J Biol Chem 2005;280:30956-30962.
19. Lang C, Murgia C, Leong M, Tan LW, Perozzi G, Knight D, Ruffin R, Zalewski P. Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol 2007;292:L577-L584.
20. Mazzatti DJ, Malavolta M, White AJ, Costarelli L, Giacconi R, Muti E, Cipriano C, Powell JR, Mocchegiani E. Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individuals. Rejuvenation Res 2007;10:603-620.